ロード中...
A HER2 bispecific antibody can be efficiently expressed in Escherichia coli with potent cytotoxicity
Bispecific antibodies have been actively studied for cancer therapy due to their potent cytotoxicity against tumor cells. A number of bispecific antibody formats have exhibited strong tumor cytotoxicity in vitro and in vivo. However, effective production of bispecific antibodies remains challenging...
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6019972/ https://ncbi.nlm.nih.gov/pubmed/29963199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8698 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|